Moxonidine 0.2mg Tablet in PCD Pharma Franchise in Ahmedabad

Moxonidine 0.2mg Tablet in Pharmaceutical Manufacturing Company in Mumbai

Moxonidine 0.2mg Tablet in Cardiac Care Pharma Franchise in Hyderabad

Moxonidine 0.2mg Tablet in Pharma Distributors & Suppliers in Pune

Moxonidine 0.2mg Tablet in Pharma Export Company in Chennai
Moxonidine 0.2mg Tablet in Pharma Franchise Opportunity in Bengaluru

Home/Products /moxonidine-0-point-2-mg-tablet

Moxofen 0.2 Tablet

Composition : Moxonidine 0.2 mg Tablet

Dosage Form : Tablet

Packaging Type : Alu Alu

Packaging : 10*10

Price : ₹95/-

Moxonidine 0.2 mg Tablet is a centrally acting antihypertensive medication from the imidazoline receptor agonist class. It selectively stimulates imidazoline I₁ receptors in the brainstem, reducing sympathetic nervous system activity, which results in lowered vascular resistance and blood pressure. Unlike older central antihypertensives such as clonidine, Moxonidine offers high blood pressure control with fewer sedative and anticholinergic effects due to its selectivity. The 0.2 mg strength is typically used as the starting dose for patients initiating therapy and can be titrated upwards based on response. Moxonidine is particularly useful in patients with metabolic syndrome, insulin resistance, or type 2 diabetes, as it has minimal impact on glucose and lipid metabolism. It provides smooth 24-hour blood pressure control with once-daily dosing and is well tolerated as monotherapy or in combination with other antihypertensives.

Read More

About the Product

Moxonidine 0.2 mg Tablet is a centrally acting antihypertensive medication from the imidazoline receptor agonist class. It selectively stimulates imidazoline I₁ receptors in the brainstem, reducing sympathetic nervous system activity, which results in lowered vascular resistance and blood pressure. Unlike older central antihypertensives such as clonidine, Moxonidine offers high blood pressure control with fewer sedative and anticholinergic effects due to its selectivity. The 0.2 mg strength is typically used as the starting dose for patients initiating therapy and can be titrated upwards based on response. Moxonidine is particularly useful in patients with metabolic syndrome, insulin resistance, or type 2 diabetes, as it has minimal impact on glucose and lipid metabolism. It provides smooth 24-hour blood pressure control with once-daily dosing and is well tolerated as monotherapy or in combination with other antihypertensives.

Common side effects include dizziness, headache, fatigue, dry mouth, and mild drowsiness, particularly during the first few days of treatment. Some patients may experience gastrointestinal discomfort or insomnia. Rarely, bradycardia, significant hypotension, or allergic reactions can occur. Most side effects are transient and subside as the body adapts to the medication.

Moxonidine 0.2 mg Tablet is indicated for the management of essential hypertension in adults, especially in patients who are not controlled with or intolerant to conventional antihypertensive medications, or those with metabolic comorbidities.

Moxonidine 0.2 mg should only be taken under medical supervision. It is contraindicated in patients with severe bradycardia, sick sinus syndrome, heart block, or advanced heart failure unless prescribed by a specialist. Dose should be tapered gradually when discontinuing to avoid rebound hypertension. Caution is advised in patients with impaired renal function; dose adjustment may be necessary. The drug is not recommended during pregnancy or breastfeeding unless the potential benefits outweigh the risks. Alcohol should be limited as it can enhance drowsiness and the hypotensive effect. Regular blood pressure monitoring and follow-up are essential during treatment to ensure safety and efficacy.

Store Moxonidine 0.2 mg Tablet in a cool, dry place below 30°C. Protect from direct sunlight and moisture. Keep the tablets in their original blister packaging and out of reach of children. Do not use beyond the expiry date printed on the strip.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation